|
|
|
| Gut Microbiota Metabolite Trimethylamine N-oxide Promotes Atherosclerosis by Inhibiting the Keap1/Nrf2 Signaling Pathway |
| SHAN Siyang, et al |
| The Sixth Affiliated Hospital of Xinjiang Medical University, Xinjiang Urumqi 830092, China |
|
|
|
|
Abstract Objective: To investigate the effects of the gut microbiota (GM) metabolite trimethylamine N-oxide (TMAO) on atherosclerosis (AS) and its related mechanisms.Methods: Male mice were randomly divided into the control group, model group, TMAO group, Keap1/Nrf2 activator RTA-408 group, and TMAO+RTA-408 group, with 12 mice in each group. The model group mice were fed a high-fat diet, while the TMAO group mice were fed a high-fat diet with 1% choline for a modeling period of 12 weeks. After modeling, mice in the RTA-408 and TMAO+RTA-408 groups received a single daily intraperitoneal injection of RTA-408 (100 μg/kg) for 14 days, while mice in other groups received equivalent amounts of saline. Biochemical analysis was used to quantify the levels of TG, TC, LDL-C, and HDL-C. Histological changes in the aorta were detected using HE, Masson trichrome, and oil red O staining. ELISA was used to detect serum levels of interleukin-1β (IL-1β), reactive oxygen species (ROS), and superoxide dismutase (SOD). Ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was used to detect plasma TMAO levels in mice. Fluorescent probe assays were used to detect ROS fluorescence intensity in the aorta. qRT-PCR and Western blot were used to detect mRNA and protein expression levels of Keap1, Nrf2, and HO-1 in mouse aortic tissue. Immunofluorescence was used to observe Nrf2 nuclear translocation.Results: Serum TC, TG, and LDL-C concentrations were higher in AS mice compared to the control group, while HDL-C concentration was lower (P<0.01). Additionally, the model group showed extensive aortic intima thickening, significant foam cell formation, and increased collagen deposition in the arterial wall. Serum levels of IL-1β, ROS, and TMAO were significantly elevated (P<0.01), while SOD activity was significantly reduced (P<0.01). Aortic ROS content increased, Nrf2 nuclear translocation was significantly inhibited (P<0.01), and mRNA and protein expression levels of Keap1, Nrf2, and HO-1 increased (P<0.01). Compared to AS mice, TMAO treatment further aggravated the changes in these indicators (P<0.05); RTA-408, however, negated the exacerbating effects of TMAO on AS mice (P<0.05).Conclusion: TMAO may exacerbate aortic pathological changes, inflammatory responses, and endothelial injury in AS mice by inhibiting the activation of the Keap1/Nrf2 signaling pathway.
|
|
|
|
|
|
[1] Semb A G,Ikdahl E,Wibetoe G,et al.Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis [J].2020,16(7):361-379.
[2] Khatiwada N,Hong Z J P.Potential benefits and risks associated with the use of statins [J].2024,16(2):214.
[3] Zhou S,Xue J,Shan J,et al.Gut-flora-dependent metabolite trimethylamine-N-oxide promotes atherosclerosis-associated inflammation responses by indirect ROS stimulation and signaling involving AMPK and SIRT1 [J].2022,14(16):3338.
[4] Saha S,Buttari B,Panieri E,et al.An overview of Nrf2 signaling pathway and its role in inflammation [J].2020,25(22):5474.
[5] Zhao Z,Wang X,Zhang R,et al.Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells [J].2021,13(8):11363.
[6] Zhang Y,Ying F,Tian X,et al.TRPM2 promotes atherosclerotic progression in a mouse model of atherosclerosis [J].2022,11(9):1423.
[7] Verhaar B J,Prodan A,Nieuwdorp M,et al.Gut microbiota in hypertension and atherosclerosis:a review [J].2020,12(10):2982.
[8] Bordoni L,Samulak J J,Sawicha A K,et al.Trimethylamine N-oxide and the reverse cholesterol transport in cardiovascular disease:a cross-sectional study [J].2020,10(1):18675.
[9] Kruger-genge A,Jung F,Hufert F,et al.Effects of gut microbial metabolite trimethylamine N-oxide (TMAO) on platelets and endothelial cells [J].2020,76(2):309-316.
[10] Oktaviono Y H,Lamara A D,Saputra P B T,et al.The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect:A literature review [J].2023,23(6):936.
[11] Gianazza E,Brioschi M,Martinez Fernandez A,et al.Lipid peroxidation in atherosclerotic cardiovascular diseases [J].2021,34(1):49-98.
[12] Alonso-Pineiro J A,Gonzalez-Rovira A,Sanchez-Gomar I,et al.Nrf2 and heme oxygenase-1 involvement in atherosclerosis related oxidative stress [J].2021,10(9):1463.
[13] Komatsu M J I L.p62 bodies:phase separation,NRF2 activation,and selective autophagic degradation [J].2022,74(12):1200-1208. |
| [1] |
. [J]. HeBei Med, 2024, 30(1): 168-171. |
|
|
|
|
2024, Vol. 30 
